5
Sep
2024
Raising the Bar for Sickle Cell Patients: Ted Love and Alan Anderson on The Long Run
Today’s guests on The Long Run are Ted Love and Alan Anderson. Ted is the chairman of the board of directors at the Biotechnology Innovation Organization. He’s perhaps best known for serving as CEO of Global Blood Therapeutics, the San Francisco Bay Area company that developed voxelotor (marketed as Oxbryta), a novel small molecule for sickle cell disease. The company... Read More